Skip to content

Clinical trials

Pulmonary Disease, Chronic Obstructive trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Country / region: Hong Kong Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20052
20063
20071
20082
20092
20103
20113
20121
20133
20141
20153
20162
20173
20193
20201
20213
20223
20232
20241
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Unknown status9
Recruiting5
Not yet recruiting3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong10
The University of Hong Kong10
AstraZeneca5
Boehringer Ingelheim5
Novartis Pharmaceuticals5
GlaxoSmithKline3
North District Hospital2
The Hong Kong Polytechnic University2
United Christian Hospital2
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive51
Asthma3
Lung Diseases3
Respiratory Insufficiency3
Acute Coronary Syndrome1
Bronchiectasis1
Bronchitis1
Bronchitis, Chronic1
Cerebrovascular Disorders1
Diabetes Mellitus1

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.